Is Aurora Cannabis (TSX:ACB) Stock a Buy Today?

The 2019 rally in marijuana stocks has investors scouring the cannabis sector to see which marijuana companies might be the best picks to pocket some pot stock gains through the end of the year. Let’s take a look at Aurora Cannabis (TSX:ACB)(NYSE:ACB) to see if it deserves to be on your buy list right now. Big appetite Aurora Cannabis currently…

Read More

Why Canopy Growth Corp (TSX:WEED) Is Still Top of the Class

Canopy Growth (TSX:WEED)(NYSE:CGC) has been one of the biggest winners of the recent explosion of the cannabis market. The company’s share price has increased at a dizzying pace over the past five years. Canopy is now the biggest pot company in the world by market cap, and with a high production capacity, about 30% of the domestic market share, and…

Read More

Canopy Growth Corp’s (TSX:WEED) Latest Acquisition Is Full of Uncertainty

Last week, Canopy Growth Corp  (TSX:WEED)(NYSE:CGC) announced the biggest deal we’ve seen in the cannabis industry thus far – a US$3.4 billion acquisition of Acreage Holdings Inc. (CNSX:ACRG.U). Although it’s a significant transaction for Canopy Growth that would make it a big player in the U.S. overnight, it may take a while before we see the deal finalized, as there is one…

Read More

Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) Looks Fired Up After Potentially Massive Deal With Acreage Holdings, Inc. (OTCQX: ACRGF) (CSE: ACRG.U)

The week of 4/20 has been a crazy one for the emerging cannabis industry, which saw the first announced cross-border corporate cannabis acquisition…well sort of. After the close on April 17, 2019, major financial news outlets, like CNBC, began to talk of an impending deal where Canadian cannabis giant, Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) was said to be…

Read More

Abattis Bioceuticals Corp. (OTC Pink: ATTBF) (CSE: ATT) Climbs 37% After Announcing Acquisition of Pro Natura BV, A Netherlands-Based Nutraceutical Company

Abattis Bioceuticals Corp.

Abattis Bioceuticals Corp. (OTC Pink: ATTBF) (CSE: ATT) operates as a Canadian medical cannabis company that has a cultivation site on Gabriola Island, impressive portfolio of 140 genetic cannabis strains, and a strong fertilizer and nutrient assets. U.S.-listed shares of the Canadian cannabis company are rallying 36.52%, through early trading on Wednesday, April 3, 2019. Over the past month, Abattis…

Read More

This Pot Stock Just Made the Biggest Acquisition Ever in the U.S. Cannabis Industry

Cresco Labs (CNSX:CL) might not be a household name in the cannabis industry yet, but that might change very soon. On Monday, the company announced that it was acquiring Origin House (CNSX:OH) in what is going to be the largest transaction for a U.S. cannabis company yet — $1.1 billion. Up until now, the big acquisitions have involved Canadian cannabis companies, and…

Read More